Introduction
Malignant diffuse large cell lymphomas of B-cell type (DLBCL) frequently develop in the pleural cavity of immunocompetent patients with at least a 20-year history of pyothorax. 1 This tumor is listed as a pyothorax-associated lymphoma (PAL) in the recent World Health Organization classification for tumors. 2 Epstein-Barr virus (EBV) is causative of several B-cell malignancies such as endemic Burkitt's lymphoma, Hodgkin's lymphoma (HL), posttransplant lymphoproliferative diseases (PTLPD) 3 and also PAL. These EBV-associated lymphomas have distinct cellular phenotypes and patterns of EBV gene expression from each other, suggesting a different role of EBV in each lymphoma. PAL is similar to PTLPD in the EBV latency pattern (Lat III), usually expressing all EBV latent gene products. PTLPD, especially those arising within 1-2 years after allograft, might be an expansion of lymphoid cells, which are directly transformed by EBV and grow in the absence of T-cell immune surveillance. 4 A recent study demonstrated that PTLPD arises from various kinds of 'crippled B cells', which might be rescued by EBV-induced transformation. 4 Interestingly, EBV-positive HL is considered to share a similar mechanism. 5 Analysis of the rearranged immunoglobulin heavy-chain variable (IgV H ) gene is commonly used to know the stage of differentiation at which neoplastic clones of B-cell lymphomas are derived from. 6 Ongoing mutational activity within B-cell lymphoma leads to clonal diversification: its analysis is used to define the differentiation stage of neoplastic B cells as germinal center (GC) or post-GC origin. 7 Previously, we reported part of the sequence of a rearranged IgV H region gene in clinical samples and a cell line. 8 The results suggested that PAL is composed of B lymphocytes at the post-GC stage of differentiation. In the present study, immunoglobulin heavy (IgH) chain and light (IgL) chain expression in relation to somatic hypermutations (SHMs) and ongoing mutations of the IgV H gene and Ig light-chain variable (IgV L ) gene were analyzed in cell lines and clinical samples from patients with PAL. In addition, class-switch recombination, another crucial step in the pathway of B cell ontogeny, was analyzed.
Materials and methods

Cell lines
Eight cell lines derived from PALs [9] [10] [11] [12] were used in this study. All cell lines were incubated in RPMI 1640 medium (Sigma, St Louis, MO, USA) supplemented with 10-20% fetal calf serum at 37 1C in a humidified atmosphere of 5% CO 2 and 95% air.
Clinical cases
Clinical samples were available from seven patients with PAL with the informed consent of the patient in print. Age of the patients at first admission for PAL ranged from 53 to 77 (median 73.0) years, with a male to female ratio of 6:1. Tumors were histologically classified as DLBCL according to the World Health Organization's classification. 13 In situ hybridization with an EBER-1 probe revealed positive signals in the nucleus of tumor cells in all PAL cases. 8, 9 Amplification and sequencing of rearranged IgV H and IgV L genes
The IgV H sequences corresponding to framework region (FR) 1-3, complementarity-determining region (CDR) 1-2 and the joining sequence (J H ) were amplified from the gDNA extracted from the tumor tissues or cell lines with primer combinations described elsewhere.
14 Amplified DNA of the expected size was sequenced, and subjected to IgBlast (http://www.ncbi.nlm. nih.gov/igblast) for the selection of the closest germ line sequences. Primer pairs that encompass the promoter region of IgV H were designed according to the results of the IgBlast analysis, and amplification was done using gDNA. For the amplification of IgV H in PAL cell lines, a long-distance inverse PCR was also carried out as described previously. 15 Non-germ-line products were purified, cloned and then sequenced as described previously. 8 Sequences obtained were analyzed with IgBlast for determination of the V(D)J family usage, and then the frequency of SHMs, presence of antigen selection, ongoing mutation and coding capacity were analyzed. Coding capacity was defined as 'not preserved' when SHMs within the IgV H gene render the coding sequence nonfunctional, or SHMs in the octamer motif of the Ig promoter or other regulatory sequences apparently abrogate the Ig transcription. An ongoing mutation was judged as 'present' when observed in at least 2 out of 12 clones sequenced 16 to ensure that base exchanges were not introduced by errors of the Taq polymerase. To evaluate the distribution of mutations among CDRs and FRs, a multinomial statistical analysis (available at www. stat.stanford.edu/immunoglobulin) was used. 17 This method gives the probability of the observed mutation pattern in CDRs and FRs having arisen by chance; probability values of less than 0.05 are regarded as significant and therefore strongly indicative of an antigen-selected Ig H genotype.
Amplification of IgH transcripts and class-switch recombination
Total RNA was extracted using the TRIzol reagent and reversetranscribed (RT) using the Superscript III First Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). Primers for the detection of IgH transcripts were designed spanning the leader sequence and the CDR3 to distinguish the spliced mRNA from a gDNA. To determine the target of class-switch recombination, reverse primers specific for m, g and a constant chains were designed. All primer sequences used for RT-PCR are summarized in Table 1 . 
Flow cytometry
Western blot
For western blot analysis, 5 Â 10 6 cells were lysed in 500 ml of sample buffer, sonicated and boiled for 5 min. Then 15 ml of lysate was separated on a 10% polyacrylamide gel and transferred onto a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, USA). The primary antibodies specific for OCT-2 (sc-233) and BOB.1 (sc-955) were purchased from Santa Cruz Biotechnology (Heidelberg, Germany). Signals were visualized with ECL plus Chemiluminescent reagents (GE Healthcare Bio-Sciences, Piscataway, NJ, USA).
Chromatin immunoprecipitation
The chromatin immunoprecipitation (ChIP) assay was carried out with a ChIP assay kit (Upstate, Lake Placid, NY, USA) according to the manufacturer's instructions. Briefly, 2 Â 10 6 cells were fixed with 1% formaldehyde for 10 min and sonicated with the ultrasonicator (Tomy Seiko, Tokyo, Japan). Immunoprecipitation was performed with 1 mg of the affinity-purified polyclonal rabbit antibodies against OCT-2, and BOB.1 proteins (Santa Cruz Biotechnology). DNA directly purified from the soluble chromatin solution was used as a positive control (input). Primers for the ChIP assay were described elsewhere. 18 
Results
Sequences of IgV H gene
The IgV H sequences in each cell line were subjected to IgBlast to determine the VDJ usage ( Figure 1a ; Table 2 ). OPL-1 was eliminated from the analysis because the IgV H gene could not be amplified. The V H 3 family gene was used in five cell lines (OPL-2, -3, -5 and -7, and Pal-1), while the V H 4 gene was used Table 1 Primer sequences used for RT-PCR Primer Name Primer sequences, 5 tion from the germ line sequence with a deletion in FR1 resulted in inactivation of the reading frame in OPL-3. The pseudogene 4-55P, which lacks the promoter sequence and has a stop codon in CDR2, was used in OPL-4. IgV H in OPL-4 also lacked the promoter sequence, and thus seems to have no coding capacity though the stop codon disappeared by SHM.
Sequencing analysis of IgV L gene
The IgV L sequences found in each cell line were subjected to IgBlast (Figure 1b ; Table 3 ). The V k -J k rearrangement was detected in four cell lines (OPL-4, -5 and -7, and Deglis), while V L -J L was detected in OPL-2. The IgV L genes were not amplified in three cell lines (OPL-1, -3 and Pal-1). Coding capacity was preserved in three of five cell lines. Substantial diversification 
IgH protein expression in PAL cell lines
The IgV H sequence analysis revealed that coding capacity was abrogated in three cell lines (OPL-3, -4 and Deglis) as described above. As expected, IgH proteins were not detected in these cell lines (Figure 2a ). In the remaining four cell lines, coding capacity was preserved because SHMs did not involve the reading frame and no mutations were found within the transcription control regions. 
Interaction of IgH regulatory regions with transactivating factors
Interaction of octamer sites with the transactivating factors OCT-2 and BOB.1 is essential for IgH expression in B cells. Levels of OCT-2 and BOB.1 in the OPL-5 and Pal-1 cells were similar to those in OPL-7 and the Burkitt cell line Raji ( Figure 3a) . A ChIP assay was performed to examine whether the regulatory regions for IgH transcription were accessible for OCT-2 and BOB.1. The rearranged allele of the IgV H promoter in the respective cell lines and the internal enhancer region containing a cluster of two imperfect octamer motifs were amplified with flanking primers (Figure 3b ). In OPL-5 and Pal-1, both OCT-2 and BOB.1 were bound to the octamer motif of the IgV H promoters and internal enhancer (Figure 3c ). Treatment with 1 mM 5-aza-dC slightly increased the binding of these proteins. OCT-2 and BOB.1 did not bind to the octamer motif of the IgV H promoters and the internal enhancer in L-428 as described previously. 18 The present data indicate that regulatory regions for IgH transcription are accessible for OCT-2 and BOB.1, and the DNA methylation partially influences the transcription. 
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Analysis of the IgV H gene in clinical samples
The IgV H gene was successfully amplified in four of seven clinical samples (Table 4 ). The V H 3 family gene was used in two cases, while V H 4 and V H 2 were used in one case each. Diversification of the IgV H gene ranged from 7.4 to 25.5%, indicating that these cells developed from B cells at the post-GC B cell stage. The coding sequence was preserved in two of four cases. Judging from the pattern of mutations, tumor cells in both Case 1 and Case 2 developed from antigen-selected memory cells (P(FR) o0.05 and/or P(CDR) o0.05). Coding capacity was abrogated in the remaining two cases due to the frameshift mutations. Deletions (19 bp) within FR1 and CDR1 were detected in Case 3, while an abnormal sequence was detected within CDR1 and two in Case 4, resulting in inactivation of the reading frame. Sequencing of the IgV H PCR products in the 12 clones revealed the absence of ongoing mutations in four clinical cases.
Discussion
In the present study, sequencing of the IgV H gene in cell lines and clinical samples indicated the PAL cells to be derived from cells at the post-GC stage of differentiation, which could be further subdivided into the following two groups; Group 1: post-GC cells with potentially productive IgV H genotypes (four cell lines, two cases), Group 2: post-GC cells with sterile IgV H genotypes (three cell lines, two cases). IgH expression in the three cell lines in Group 2 was abrogated as expected. In addition, IgH expression was also abrogated in each cell line in Group 1, probably as a consequence of epigenetic silencing. Whereas it should be considered that a GC B cell undergoing malignant transformation may well have silenced hypermutations as a consequence of the transformation process, therefore a lymphoma without ongoing hypermutation may well be histogenetically derived from a GC and not a post-GC B cell. Most Group 1 PAL cells may arise from the pool of antigenselected post-GC (memory cells) with antigen selection. PAL cells are EBV positive, therefore this finding is consistent with the report that EBV latently infects memory B cells of immunocompetent individuals. 19 However, there were two exceptional cell lines (OPL-2 and Pal-1), in which the distribution of mutations among CDRs and FRs did not deviate significantly suggesting that antigen selection did not take place. PAL cells in Group 2 showed the genotypes of crippled B cells, that is, unresponsive to antigenic stimuli, which are destined to die by apoptosis in the absence of EBV infection. The findings suggest that EBV-transformed B-lymphocytes escape negative selection within GCs. These 'crippled B' cells as the source of PAL cells might be similar to those of EBV-positive HL and PTLPD. A previous analysis of the Ig gene revealed that HL could be derived from atypical post-GC cells with random, frequently inactivating mutations, which are quite different from SHMs found in classic antigen-selected memory B cells. induces expression of a number of antiapoptotic cellular genes and activates nuclear factor-kB. 21, 22 LMP-2A is reported to be a substitute for the BCR in transgenic animals. 23 Therefore, LMP-2A might play a critical role in the rescuing of BCR-defective GC B cells in vivo and in vitro. This molecular mimicry might constitute an important survival signal for GC B cells, since LMP-2A expression could rescue proapoptotic B cells with a nonfunctional or defective BCR from the default apoptotic pathway. Recent study demonstrated that EBV infection could rescue proapoptotic GC B cells with crippled mutations at the IgH locus from apoptosis. 24 Hodgkin and Reed-Sternberg (HRS) cells in HL are unable to produce both IgH and IgL chains despite the presence of clonally rearranged IgH and IgL genes. 25 Several explanations have been proposed for this: (1) about 25% of HRS cells have 'crippled' mutations within the transcription control regions and/or in the coding sequence, 5,7 (2) absent or diminished production of critical transcription factors such as OCT-2 and BOB.1 26 and (3) epigenetic silencing. 18 The 'crippled' mutations and epigenetic silencing were found in 3 and 2 PAL cell lines, respectively, suggesting the presence of a similar mechanism for Ig downregulation in PAL to HL.
It is interesting that the PAL cell lines had either the IgA 1 or IgA 2 transcript, because the ordinary type of DLBCL derived from post-GC cells has IgM as an isotype. 27 During the differentiation, early B cells express IgM, while mature B cells express various subtypes of Ig as a result of class-switch recombination. Recombination to IgA in B cells is induced by transforming growth factor-b secreted from activated T cells, 28 suggesting that cytokines locally produced in the chronic pyothorax influence the class-switch recombination. In healthy individuals, IgA 1 is secreted mainly in sputum and breast milk. It is worth investigating whether IgA 1 -secreted cells are frequently present in the pyothorax lesions from which PAL develops.
Taken together, PAL may be derived from cells at the post-GC stage of differentiation, mostly with crippled IgH genotypes. These cells survive due to transformation by EBV infection, which might provide the basis for the development of PAL with additional genetic changes. This scenario could apply to most EBV-positive HL and PTLPD. Reactive oxygen species and cytokines produced in the pyothorax lesions may contribute to the genetic change as well as the unique class-switch recombination.
